MACI (Vericel Corporation)
Welcome to the PulseAid listing for the MACI drug offered from Vericel Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
| LABELER NAME / MANUFACTURER: | Vericel Corporation |
| NON-PROPRIETARY NAME: | autologous cultured chondrocytes |
| SUBSTANCE NAME: | AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN |
| TYPE: | CELLULAR THERAPY |
| PHARMA CLASS: | Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] |
| ROUTE: | INTRA-ARTICULAR |
| DOSAGE FORM: | IMPLANT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-01-11 |
| END MARKETING DATE: | 0000-00-00 |
MACI CELLULAR THERAPY Details:
| Item Description | MACI from Vericel Corporation |
| LABELER NAME: | Vericel Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15000000; 15(1/1; cm2/1) |
| START MARKETING DATE: | 2017-01-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69866-1030_a6afee99-4a95-4488-84d8-7bdea7e9bbe3 |
| PRODUCT NDC: | 69866-1030 |
| APPLICATION NUMBER: | BLA125603 |
Other AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN Pharmaceutical Manufacturers / Labelers:
